CLINICAL_TRIALS
ClinicalTrials.gov record update
CD19-Directed Chimeric Antigen Receptor Autologous T Cells (CART19) for Adolescents and Young Adults With Systemic Lupus Erythematosus (SLE)
This page presents selected fields from the linked source record. It does not add a medical interpretation.
Record identity and dates
- Source
- ClinicalTrials.gov
- Source record ID
- NCT06839976
- Title field or adapter rule
- protocolSection.identificationModule.officialTitle
- Ingested At
- 2026-04-25T22:28:23.261162+00:00
- Published At
- 2026-02-23T00:00:00+00:00
- Record Updated At
- 2026-02-23
- Timestamp Basis
- source retrieval time was not retained by the feed adapter
- Date limitation
- source retrieval time was not retained by the feed adapter
Fields recorded by this source
- protocolSection.conditionsModule.conditions
["SLE", "Systemic Lupus Erythematosus (SLE)", "CAR T Cell", "CART19", "Cell Therapy", "Lupus", "Lupus Nephritis (LN)"]- protocolSection.statusModule.lastUpdatePostDateStruct.date
"2026-02-23"- protocolSection.identificationModule.nctId
"NCT06839976"- protocolSection.identificationModule.officialTitle
"CD19-Directed Chimeric Antigen Receptor Autologous T Cells (CART19) for Adolescents and Young Adults With Systemic Lupus Erythematosus (SLE)"- protocolSection.statusModule.overallStatus
"RECRUITING"- protocolSection.designModule.phases
["PHASE1", "PHASE2"]- protocolSection.statusModule.resultsFirstPostDateStruct.date
""
Study condition terms
Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.
This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.